In recent studies using a rat aortic balloon occlusion model, we have demonstrated that spinal grafting of rat or human neuronal precursors or human postmitotic hNT neurons leads to progressive amelioration of spasticity and rigidity and corresponding improvement in ambulatory function. In the present study, we characterized the optimal dosing regimen and safety profile of human spinal stem cells (HSSC) when grafted into the lumbar spinal cord segments of naive immunosuppressed minipigs. Gottingen-Minnesota minipigs (18-23 kg) were anesthetized with halothane, mounted into a spine-immobilization apparatus, and received five bilateral injections of HSSC delivered in 2, 4, 6, 8, or 10 µl of media targeted into L2-L5 central gray matter (lamina VII). The total number of delivered cells ranged between 2,500 and 100,000 per injection. Animals were immunosuppressed with Prograf for the duration of study. After cell grafting, ambulatory function was monitored daily using a Tarlov's score. Sensory functions were assessed by mechanically evoked skin twitch test. Animals survived for 6-7 weeks. Three days before sacrifice animals received daily injections of bromodeoxyuridine (100 mg/kg; IV) and were then transcardially perfused with 4% paraformaldehyde. Th12-L6 spinal column was then dissected; the spinal cord was removed and scanned with MRI. Lumbar transverse spinal cord sections were then cut and stained with a combination of human-specific (hNUMA, hMOC, hNSE, hSYN) or nonspecific (DCX, MAP2, GABA, CHAT) antibodies. The total number of surviving cells was estimated using stereological quantification. During the first 12-24 h after cell grafting, a modest motor weakness was observed in three of eight animals but was no longer present at 4 days to 7 weeks. No sensory dysfunction was seen at any time point. Postmortem MRI scans revealed the presence of the individual grafts in the targeted spinal cord areas. Histological examination of spinal cord sections revealed the presence of hNUMA-immunoreactive grafted cells distributed between the base of the dorsal horn and the ventral horn. In all grafts intense hMOC, DCX, and hSYN immunoreactivity in grafted cells was seen. In addition, a rich axodendritic network of DCX-positive processes was identified extending 300-700 µm from the grafts. On average, 45% of hNUMA-positive neurons were GABA immunoreactive. Stereological analysis of hNUMA-positive cells showed an average of 2.5-to 3-fold increase in number of surviving cells compared with the number of injected cells. Analysis of spinal structural morphology showed that in animals injected with more than 50,000 cells/injection or volumes of injectate higher than 6 µl/ injection there was tissue expansion and disruption of the local axodendritic network. Based on these data the safe total number of injected cells and volume of injectate were determined to be 30,000 cells delivered in ≤6 µl of media. These data demonstrate that highly reproducible delivery of a potential cell therapeutic candidate into spinal parenchyma can be achieved across a wide range of cell doses by direct intraspinal injections. The resulting grafts uniformly showed robust cell survival and progressive neuronal maturation.
INTRODUCTION
erably fewer studies that employ large animals such as cat, dog, minipig, or primates (7, 18, 33, 42, 48) . Accordingly, there are no systematic data defining the possible Several spinal neuropathological conditions can lead to region-specific neuronal degeneration and resulting differences in the differentiation and survival profile of the same cell line when grafted in larger species. Indeed, loss of neurological function. Depending on the phenotype of the injured/lost neurons and the functional net-prominent differences exist in spinal cord dimensions across species ranging from the commonly employed work in which they are involved, such a neurological dysfunction can be qualitatively expressed as parapare-mouse and rat models to humans. Aside from simple implant survival in different species, it is not clear how sis or fully developed spastic or flaccid paraplegia with a possible degree of sensory dysfunction such as hypoal-spinal dimensions will influence the magnitude of sprouting. It is reasonable to conclude that such informa-gesia or allodynia. Accordingly, the pathological conditions leading to the development of these distinct patho-tion may well impact the number of cells necessary to produce a physiologically relevant contribution after re-logical states can be divided into several categories depending on the profile of neuronal loss.
placing the lost neuron population. Thus, prior to human use, larger animal models must be validated so as to First are those conditions that cause preferential degeneration of small and medium-sized interneurons. In serve in developing optimal cell delivery protocols. Accordingly, in the present toxicity-dosing study, we this category, transient spinal cord ischemia has been shown to lead to a selective degeneration of inhibitory characterized the survival and differentiation profile of human spinal stem cells when grafted into the lumbar interneurons (but with continuing presence of functional α-motoneurons) (25, 28, 39, 40, 44) . Neurologically the spinal cord of naive immunosuppressed minipigs. We chose the minipig because of its availability, spinal di-functional deficit in such animals as well as in humans is typically expressed as chronically increased muscle mensions, and, as compared to primates, its cost effectiveness. The overall goals of the study were to define: tone (i.e., rigidity), and combined with a stimulusdependent increase in muscle activity (i.e., spasticity) i) the optimal total number of grafted cells per injection as defined by the integrity of the host spinal cord tissue (17, 20, 26) . Second are those conditions that lead to a selective degeneration of α-motoneurons and corre-and local inflammatory changes; ii) the optimal volume of the individual injections; and iii) corresponding sponding loss of motor tone. Among those, amyotrophic lateral sclerosis (ALS) has been shown to lead to a pro-changes in neurological function associated with spinal grafting. gressive degeneration of cervical and lumbar α-motoneurons and resulting loss of ambulatory function and MATERIALS AND METHODS ultimately respiratory failure (14, 38, 47) . Third, a selective loss of small inhibitory interneurons localized in the These studies were carried out under protocols approved by the Institutional Animal Care and Use Com-dorsal horn has been described to be involved in part in the development of chronic pain states after peripheral mittee of the Czech Academy of Sciences and were in compliance with The Association for Assessment of nerve injury (19, 37) . A separate category is presented by the pathologies that lead to the loss of local myelin Laboratory Animal Care guidelines for animal use. All studies were performed in such a manner as to minimize (such as seen in multiple sclerosis) and resulting loss of signal conductivity (41) . group size and animal suffering. In previous studies, we have demonstrated that spinal Derivation of the Spinal Human Spinal Stem grafting of rat or human spinal neuronal precursors or Cells (HSSC) fully postmitotic hNT neurons is associated with a significant improvement of neurological function in rats Human SSCs were prepared from the cervical upper thoracic region of spinal cord tissue obtained from a sin-after spinal ischemic injury (8, 27) . Previous reports also describe long-term survival, integration with the host tis-gle 8-week human fetus after an elective abortion. The fetal tissue was donated by the mother in a manner fully sue, and functional improvement after spinal grafting of neural precursors or postmitotic neurons in mice or rat compliant with the guidelines of NIH and FDA, and approved by an outside independent review board. The spi-spinal injury models or in an ALS transgenic rat model (1, 3, 22, (29) (30) (31) 34, 46, 49, 52) . Jointly, these data suggest nal cord tissue was removed of meninges and dorsal root ganglia, and dissociated into a single cell suspension by that region-specific grafting of neural or neuronal precursors can represent a viable approach for cell replace-mechanical trituration in serum-free, modified N2 media. The modified N2 media was composed of: 100 mg/ ment therapy intended to modulate a functional deficit particularly when the dysfunction results from a well-L human plasma apo-transferrin, 25 mg/L recombinant human insulin, 1.56 g/L glucose, 20 nM progesterone, defined cell loss.
While there are numerous spinal grafting studies that 100 µM putrescine, and 30 nM sodium selenite in DMEM/F12. For growth of the HSSC, 10 ng/ml bFGF use rat or mouse degenerative models, there are consid-as the sole mitogen was added to the modified N2 media and atropine (1 mg/kg; Biotika, SK) and then induced with ketamine (20 mg/kg; IV). After induction, animals (growth media). The initial culture was serially expanded as a monolayer culture in precoated flasks (T-were intubated with a 2.5F tracheal tube. Anesthesia was maintained with 1.5% isoflurane in 50%/50% air/oxy-175) or plates (150 mm, Nunc) (16). Briefly, the precoated vessels were prepared by incubating them for 1 gen mixture at a constant 2 L/min flow rate. Oxygen saturation was monitored throughout the procedure us-h at room temperature with 100 µg/ml poly-D-lysine in 10 mM HEPES buffer at 0.165 ml/cm 2 . The vessels ing a pulse oximeter (Nellcor Puritan Bennett Inc., Ireland). After induction of anesthesia, animals were placed were washed three times with water and allowed to completely dry aseptically in the hood. They were then fur-into a supine position with all four extremities fixed to the operating table. The left jugular vein was exposed ther incubated with 100 µg/ml fibronectin/PBS for 5 min or alternatively 25 µg/ml fibronectin/PBS for 1 h. and catheterized with an 18-gauge central venous catheter (Certofix Mono V 330; B Braun, Germany). The end The fibronectin solution was aspirated and the vessels were used immediately without drying.
of the catheter was externalized on the side of the neck. Animals were then placed into a prone position and pre-Approximately 6.1 × 10 6 total cells were obtained upon the initial dissociation of the spinal cord tissue. All pared for spinal cell grafting (see following paragraph). All surgical interventions followed rigid aseptic proce-of the cells were plated onto one 150-mm plate in 20 ml of the growth media. The growth media was changed dures. All materials were subjected to autoclaving or gas sterilization. every other day and on the alternate days 10 ng/ml of bFGF was directly added to the culture. The first pas-Immobilization of the Lumbar Spinal Cord and Dorsal sage was conducted 16 days after plating. At this point, L2-L4 Laminectomy (Fig. 2 ) the culture was composed mostly of postmitotic neurons and mitotic HSSC. The mitotic cells were harvested by To immobilize the lumbar spinal cord, a spinal immobilization apparatus was designed and constructed. It brief treatment with trypsin (0.05% + 0.53 mM EDTA). Trypsin was stopped by addition of soybean trypsin in-consists of a stainless steel platform (20″ × 35″), four vertical bars (2″ × 2″ and 15′ tall), and four horizontal hibitor to 0.05% final concentration. The cell suspension was triturated with a pipette to obtain a single cell sus-bars. To achieve immobilization of the lumbar spine, the lumbar portion of the animal was lifted 5′ above the pension and centrifuged at 1400 rpm for 5 min. The cell pellet was resuspended in growth media and the cells were operating table and four horizontal bars were slid bilaterally against the lateral portion of the vertebral column replated in new precoated plates at 1.2 × 10 6 cells in 20 ml of growth media per 150-mm plate. The cells were just ventral to the L3-L5 paravertebral muscle ( Fig. 2B , B′). The skin was left intact. A dorsal laminectomy of harvested at approximately 75% confluence, which occurred in 5-6 days. This process was repeated for 20 L2-L5 vertebrae, corresponding to L3-L6 spinal segments, was then performed and epidural fat removed us-passages. At various passages, the cells were frozen in the growth medium plus 10% DMSO at 5 × 10 6 -10 × ing cotton swabs. The dura was left intact. 10 6 cells/ml using a programmable freezer. The frozen
Immunosuppressive Treatment cells were stored in liquid nitrogen. Upon thawing, the overall viability and recovery was typically 80-95%.
Immediately after jugular vein catheterization the animals received a bolus (0.1 mg/kg; IV) injection of Pro-The resulting cell line, which was produced by epigenetic means only, using bFGF as the sole mitogen, was graf followed by 0.025 mg/kg delivered in 12-h intervals. Prograf plasma concentration was monitored at named "566RSC." A cell bank of passage 16 cells was prepared and used for this study (see below).
2-day intervals for the first 10-14 days and then at 7day intervals for the duration of the study using RIA To characterize the phenotype of HSSC after in vitro differentiation, cells were cultured on poly-D-lysine/fiassay. Targeted plasma concentration was 30 ng/ml. bronectin-coated chamber slides (LAB-TEK, IL) in the Cell Preparation and Spinal Cell Injections presence of DMEM/F12 + 10% FBS for 3 weeks. Cells were then fixed with 4% paraformaldehyde and stained Three days before grafting HSSC were shipped at −70°C (Neuralstem Inc., MD) to the animal grafting fa-with a combination of doublecortin (1:1000, Chemicon), MAP2 (1:1000; Chemicon), or GFAP (1:1000; Chemi-cility. Prior to injections, cells were washed two times in 37°C DMEM, centrifuged, and resuspended in DMEM. con) antibodies using a standard immunofluorescence protocol ( Fig. 1 ).
Before and after implantation the viability of cells was tested using fluorescein diacetate/propiodium iodide or General Animal Preparation trypan blue technique. On average, 80-90% viable cells were counted. Three experimental groups were used. In Minipigs resulting from cross-breeding of Minnesota and Gottingen strains (both sexes; 18-23 kg) were pre-the first group (group A, n = 4), cells were delivered in a fixed volume (2 µl) with increasing total cell number medicated with intramuscular azaperonum (2 mg/kg) per injection (2,500, 5,000, 10,000, 50,000, or 100,000
Bromodeoxyuridine (BrdU) Administration cells). In the second group (group B, n = 4), cells were Three days before sacrifice, animals received a daily delivered in increasing volume of injections (2, 4, 6, 8, bolus injection of BrdU (100 mg/kg, IV; Sigma). The or 10 µl) and increasing total cell number (2,500, 5,000, solution was injected through the jugular vein catheter 10,000, 50,000, or 100,000 cells) ( Fig. 2A ). In the third and then flushed with 10 cc of saline. group (group C, n = 6), cells were delivered in a fixed volume (6 µl) and fixed total cell number (30,000 cells).
Perfusion Fixation In Vivo The third group was performed after completion of At 6-7 weeks (groups A and B) or 4 weeks (group groups A and B study, which identified the optimal cell C) after cell grafting animals were deeply anesthetized engraftment criteria (i.e., local tissue injury, inflammawith pentobarbital (100 mg/kg) and transcardially pertion and cell distribution) for a specific injection volume fused with heparinized (4 U/ml) PBS (137 mM sodium and total cell number. chloride, 2.7 mM potassium chloride, 8 mM sodium Each animal received a total of 10 injections (5 on phosphate dibasic, and 1.47 mM potassium phosphate each side) targeted into the intermediate zone (lamina monobasic), followed by 4% paraformaldehyde (5 L; pH VII) of L2-L5 segments. The distance between individ-7.4). The spinal cords were then removed and postfixed ual injections was 1-1.5 mm. In a preliminary study usfor 24 h in 4% paraformaldehyde at 4°C. After postfixaing transverse spinal cord sections prepared from L3-L4 tion, spinal cord tissue was cryoprotected in 10%, 20%, segments of 18-23 kg minipigs, the distance from the and 30% sucrose with 0.02% sodium azide and 10-40surface of the spinal cord to the intermediate zone was
µm-thick sections cut on a cryostat or vibratome. Before measured to be 2.5 mm. The duration of the individual cryosectioning, lumbar spinal cords were imaged by injections was 60 s followed by a 2-min period to allow MRI (see following paragraph). sufficient distribution of the cells in the individual injection sites before the needle was removed and reposi-Postmortem Magnetic Resonance Imaging tioned.
The excised spinal columns were imaged while immersed in perfluorocarbon (Solvay Solexis Bollate (MI),
Spinal Cell Delivery
Italy). Images were acquired in a horizontal bore 7-T To deliver cells, the XYZ manipulator (M325; WPI, MRI (GE Medical Systems, Milwaukee, MN), with a Sarasota, FL, USA) was used and mounted directly to 10-mm transmit/receive MR imaging surface coil using the operating table. The three-directional range of the a 2D FSPGR sequence TR/TE = 10/2.9, FA 20°C, FOV manipulator was 3 inches. A Hamilton syringe with a 10 mm, matrix 160 × 128, and a slice thickness of 100 30-gauge needle was then mounted into the manipulator µm. Imaging time was 60 min. and connected to the microinjector (Stoelting) using PE-Three-Dimensional Rendering and Anatomical Mea-50 tubing. To connect the PE-50 tubing to the Hamilton surements. Volume and surface rendering of the image syringe, the plunger was removed and one end of the data sets was performed manually using AMIRA soft-PE-50 tubing was inserted 1 cm into the syringe and ware (Mercury Computer Systems, Chelmsford, MA) to sealed with silicone. The total length of the PE-50 tubproduce quantitative three-dimensional models. From ing between the microinjector and the syringe was 35 these computed models, dimensions such as transplant cm.
volume and surface area at each transplant site can be Evaluation of Neurological Function determined. Motor functions were assessed according to a Tarlov's Immunohistochemical Staining score: grade 0: spastic or flaccid paraplegia-no movement of the joints in the lower limbs; grade 1: slight Spinal cord sections were stained using standard immunostaining protocols. The abbreviated list and the de-movement of joints in the lower limbs; grade 2: good movement of joints but unable to stand; grade 3: ability scription of the primary antibodies and the concentration used are summarized in Table 1 . Detection of primary to stand and walk but ataxia persists; grade 4: complete recovery, no detectable deficit. Sensory functions were antibodies was performed by fluorescence-conjugated goat anti-rat, anti-rabbit, or anti-mouse secondary anti-assessed by the presence of the withdrawal response to a mechanical stimulus. The toes of the front and hind bodies (Alexa 488, 594, 680; 1:250; Invitrogen). All blocking, primary, and secondary antibody preparations limbs were progressively compressed with Halsted forceps. Typically, partial application of forceps would were made in 0.1 M PBS/0.2% Triton X-100 + 5% normal goat serum. Following a 3-h block (4°C), sections evoke a vigorous withdrawal response, and the stimulus was stopped immediately. The response was scored as were incubated in primary antibody for 72 h at 4°C followed by three PBS washes (5 min each) and incubation present or absent.
with secondary antibody for 1 h at room temperature chemical protocol. For quantification, a total of 10 sections were used, with approximately 100-µm spacing be-(RT). In control experiments, primary antibodies were omitted. For general nuclear staining, DAPI (1 µl/ml) tween sections. High resolution mosaic images of these sections were obtained with a Zeiss Observer Z1 micro-was added to the final secondary antibody solutions. Slides were analyzed with Leica (DMLB) or Olympus scope system with 40× objective using Zeiss AxioVision (Ver 4.7) software, Multidimensional Acquisition MosiaX Fluorescence microscope (DMLB). Images were obtained with Olympus or Hamamatsu firewire camera and feature. To facilitate consistent NeuN-positive nuclei counting between sections and species, images were an-processed (multiple color overlay) by Adobe Photoshop 7.0 (Adobe Systems, Mountain View, CA). In colocali-alyzed using the Measuring and Counting feature of Image Pro Version 6.3 (Media Cybernetics) by defining a zation analyses, images were captured with an Olympus confocal microscope (Fluoview 1000). In general, opti-manual pixel intensity threshold specific for only positive nuclei. Total neuronal surface area (TNS; surface cal sections spaced by 0.2-0.5 µm were taken. Digital images of blue, green, red, and far red fluorescence were area occupied by NeuN-stained neurons) and gray matter surface area (GMS; surface area in which neurons captured for each optical section. The intensity values for each color were kept within the linear range of the are distributed) were also determined using calibrated parameters loaded into the Measuring and Counting fea-camera. Objectives included 40× and 60× oil immersion (numerical aperture 1.3).
ture, allowing for the calculation of TNS/GMS ratio (T/ G). The primary goal of these quantitative studies were Stereological Quantification of Grafted Cells, to provide comparative data on the neuronal numbers Qualitative Immunofluorescence Staining, and the spatial distribution of neurons in the gray matter and Confocal Microscopy in commonly used small rodent and preclinical large animal model. The total numbers of grafted cells immunoreactive for the hNUMA antibody were estimated using stereo-Identification of DCX Expression in Porcine Fetus logical, unbiased, and systematic sampling (45) . Every
One female minipig was euthanized at 86 days of tenth previously stained section (30 µm thick) taken pregnancy. Fetuses were dissected from the uterus and from animals in groups A and B were used for stereoperfusion fixed with 4% paraformaldehyde. For fixation logical quantification after applying fractionator samthe perfusion cannula was directly inserted into descendpling scheme. The optical images (1 µm thick) were obing aorta and the aorta was then clamped just below the tained with a Leica DMLB microscope using a 100× oil aortic bifurcation. Frozen transverse spinal cord sections objective with numerical aperture 1.3. The total number (30-40 µm) were then prepared as described before and of grafted cells were then calculated by applying the stained with a combination of DCX and NeuN anti-
bodies. N is a total number of positive nuclei, Q is sum of cells counted, hsf is the height sampling fraction, asf is area RESULTS sampling fraction, and ssf is slice sampling fraction. In-In Vitro Differentiation of HSSC dividual cell nuclei were counted by using an optical Dissector (Ellipse, SK). 3D reconstruction from Z-stack Staining of differentiated HSSC with hNUMA, DCX, confocal optical images (0.5 µm thick) was done utiliz-MAP2, and GFAP antibodies revealed a mixed populaing Improvision Volocity software Version 5.0.4. For tion of DCX/MAP2+ neurons and GFAP immunoreacqualitative immunofluorescence staining, sections pretive astrocytes at 3 weeks after induction ( Fig. 1A-C ). pared from animals receiving between 2,000 and 30,000
Neurological Assessment cells/injection were used.
All grafted animals in groups A and B showed near Neuronal Quantification in Lumbar Spinal Cord normal motor function upon recovery from anesthesia. in Mice and Pigs
In three of eight animals, slight ataxia and motor weakness was noted for the first 24 h (Tarlov score: 3) after Naive adult male laboratory mice (C57; 25-30 g; n = 3) and Gottingen-Minnesota minipigs (18-23 kg;
surgery, but was no longer seen at intervals longer than 4 days after cell grafting. No detectable changes or deten = 3) were terminally anesthetized and transcardially perfused with heparinized saline followed by 4% para-rioration of ambulatory function was then seen for the duration of study (4-7 weeks). Similarly, all animals formaldehyde. Frozen transverse spinal cord sections taken from the L3-L5 segments (10 µm) were then pre-showed normal responses to a peripheral nociceptive stimulus, which remained unchanged for the duration of pared, mounted on silane-coated slides (Fisher), and stained with (Ms) anti-NeuN (Chemicon MAB377) 1:
the study. In group C, a similar neurological recovery was seen and all animals showed normal motor and sen-1000, according to standard fluorescent immunohisto-sory function at intervals longer than 1 week after graft-moderate level of nonspecific staining in the nuclei of neurons as well as in glial cells of the host. ing. No spontaneous vocalization was noted in any animal.
Effect of Injection Volume on Spinal Morphology Macroscopic Examination of Grafted Spinal
Using injection volumes of 2, 4, or 6 µl per injection Cord Segments and total cell numbers between 2,000 and 30,000/injection, no detectable morphological changes were identi-Examination of the epidural space at the site of a prefied and the majority of deposited cells were typically vious laminectomy revealed the presence of residual epiconcentrated around the core of the injection (Fig. 3C , dural hematoma in two animals (Fig. 2C) . No detectable D). At 8-10 µl per injection (total cell number delivered macroscopic spinal cord changes were seen in any ani-50,000 or 100,000, respectively), the distribution of inmal and both dorsal as well as ventral spinal cord morjected cells was more irregular, often forming partially phology including the dorsal and ventral root entry zone fused two to three areas of relatively high cell densities had a normal appearance (Fig. 2D ).
( Fig. 3F ). In addition, a much more pronounced spread of injected cells in the injection tract was noted ( In animals injected with 50,000 or 100,000 cells per spinal cord segments revealed that the grafts were visuinjection, clear tissue expansion was seen in individual ally distinguishable (Fig. 3A, red arrows) . Using analyinjection sites. This was evidenced by the loss of neurosis of sequentially cut sections, the presence of all indifilament-stained processes in the areas densely packed vidual injections as well as needle tracts could be with grafted NUMA-positive cells (Fig. 3L-N) . High identified in all animals. The optical density of the grafts power microscopic analysis of these areas showed diswas very similar as seen in the host neurons (Fig. 3A, ruption of NF-positive processes derived from the host blue arrows). neurons (Fig. 3M, inset) . The degree of tissue expansion was independent of the volume of injectate used to de-MRI Analysis liver 50,000 or 100,000 cells (i.e., 2, 8, or 10 µl) while, Individual grafts were clearly identified by the presas indicated above, more cell spread was noted in injecence of an increased density in the gray matter, which tion volumes of 8 or 10 µl. corresponded to the locations of individual injections While small areas of densely packed cells were also ( Fig. 3B, red arrows) . Using the stack of MRI images, a identified in animals receiving 2,000, 5,000, 10,000, or 3D reconstruction of the spinal cord confirmed the local-30,000 cells/injection (delivered in 2, 4, or 6 µl), the ization of the individual injections as well as needle degree of tissue expansion was much less pronounced. tracts (Fig. 3K , green-needle track, red-core of cell An example of an animal receiving 30,000 cells/injecinjections). The localization of individual grafts identition in 6 µl is shown in Figure 3O , P, and R. fied by MRI analysis was then confirmed by matching the spinal cord sections prepared from the same injected Grafted hNUMA-Positive Cells Show Colocalization region and stained with human specific NUMA antibody With MAP2 and DCX (Fig. 3C-F) .
Triple labeling with hNUMA, DCX, and MAP2 antibody showed numerous solitary DCX/NUMA-positive Immunofluorescence Staining and Cross-Reactivity neurons that migrated towards ventral α-motoneurons of Human-Specific Antibodies With Porcine Spinal and were found to reside in the vicinity of α-motoneuro-Cord Cells nal membranes. Associated with these solitary neurons was an extensive dendritic tree colocalized with MAP2 Five different human-specific antibodies were used, which included: hMOC, hNUMA, hNSE, and two syn-immunoreactivity ( Fig. 4A -G, see red arrows). No CHAT immunoreactivity was found in grafted cells. aptophysin antibodies. hMOC and hNUMA showed no detectable cross-reactivity with the host tissue. In con-Staining with GFAP, hNUMA, and DCX antibody revealed only occasional presence and weakly stained trast, NSE was strongly expressed in all porcine spinal cord neurons. The first hSYN antibody showed strong GFAP/NUMA-positive cells (not shown) with the majority of NUMA-positive cells being DCX immunoreac-reactivity in the porcine spinal cord. The second hSYN antibody (see Table 1 for details) was only expressed tive ( Fig. 4H-N) . Staining with hNSE antibody, while clearly identified in the areas of the individual grafts, but also showed a within the grafts, showed a relatively weaker expression hNUMA antibody ( Fig. 6G-I) . Quantification of NUMA/ GABA-immunoreactive cells showed that, on average, as compared to the host neurons (not shown). Omitting the primary hNSE antibody showed no specific staining 45 ± 11% of hNUMA-positive cells were GABA immunoreactive. in the graft or in the host neurons.
Development of Synaptophysin Immunoreactivity
Changes in Endogenous GFAP in Grafted Neurons and IBA1 Immunoreactivity Staining of spinal cord sections with human nonspe-In comparison to control naive animals, no detectable cific SYN antibody (Fig. 5A) , human-specific SYN antidifferences in GFAP or IBA1 staining pattern in any body (Fig. 5B) , and DCX antibody (Fig. 5C, blue) recell-grafted group were seen ( Fig. 7A-L) . Only in some vealed numerous DCX-positive processes extending sections occasional hypertrophic astrocytes surrounding 300-700 µm from the grafts. In the same region, a dense grafted NUMA-positive cells were seen in the core of hSYN immunoreactivity was identified. All hSYN-posithe graft (Fig. 7H) . The presence of hypertrophic astrotive terminals were associated with DCX-positive axons cytes was independent of the total number of cells inand dendrites. Confocal analysis of 0.3-µm-thick optical jected or volume of injectate. Similarly, no detectable sections stained with human nonspecific and humandifferences in IBA1 staining pattern was seen in any specific SYN antibody showed a colocalization of both cell-grafted group and no sign of microglial activation antibodies ( Fig. 5D-G) . Some DCX-positive fibers were was identified if compared to control naive animals ( 
Incorporation of BrdU in Proliferating Stereological Quantification of hNUMA-Positive Cells hNUMA-Positive Grafted Cells
Systematic stereological quantification of hNUMA-Double labeling with BrdU and hNUMA antibody positive cells in groups A and B revealed an average of showed less than 2% of BrdU/hNUMA-positive cells.
2.5-to 3-fold increase in the total number of cells as The majority of these cells were localized at the periphcompared with the number of cells injected ( Table 2) . A ery of the individual grafts ( Fig. 6A-F) . In addition, a relative increase in the total number of cells was similar dense population of BrdU-positive cells was noted, across the grafts with variable initial total number of which were hNUMA negative, and localized in struccells injected and volume of injectate. tures that morphologically resembled the distribution of endothelial cells in newly formed vasculature (not
Neuronal Quantification in Lumbar Spinal Cord shown). of Naive Mouse and Minipig Development of GABA Immunoreactivity
Systematic quantification of total neuronal numbers in a Subpopulation of Grafted Neurons in lumbar spinal cord sections taken from an adult naive mouse and minipig (Fig. 8A, B ) showed on average 692 Staining with GABA antibody showed numerous GABA-immunoreactive neurons that colocalized with ± 46 neurons in mouse and 584 ± 17 in minipig. The gray matter surface area (GMS) measured in mouse was 0.857 mm 2 and was 2.9 mm 2 in minipig. The total neuron surface area (TNS) in mouse was 0.10 mm 2 and was 0.11 mm 2 in minipig. Calculated TNS/GMS ratio in mouse was 4.7 while in pig it was 26.4. Expressed in percentage, neurons in L2-L5 segments occupy 21% of gray matter in mouse while it is 4% in pig.
Expression of DCX in Developing Porcine Spinal Cord
In a separate control experiment, staining of transverse spinal cord sections taken from 86-day-old pig fetus revealed the presence of clearly stained DCX-immunoreactive and NeuN-positive neurons. The majority of these neurons were localized in the center of gray matter (Fig. 9A ). No DCX expression was seen in adult minipig spinal cord (Fig. 9B ).
DISCUSSION

Reaction of the Host Spinal Cord to HSSC Grafts
As we have demonstrated in the present study, individual grafts were readily identified in grafted spinal cord segments with the total number of counted cells at 6-7 weeks after grafting being two-to threefold higher than the total number of cells that were originally injected. Analysis of local host tissue reaction to a progressively increased number of injected cells showed no significant differences and the GFAP and IBA1 staining pattern was similar as seen in control nongrafted animals. Only in some sections occasional presence of reactive astrocytes was seen, but the presence of these reactive astrocytes was independent of the volume of injectate or the total number of cells injected. In addition, a homogenous presence of host-derived astrocytes within individual grafts was noted. We speculate that the lack of any significant inflammatory changes in grafted animals is in part the result of immunosuppressive treatment and resulting lack of graft rejection. These data are in agreement with our previous data using immunosuppressed rats spinally grafted with HSSC or hNT neurons (8, 27) .
A second criterion that was used in the present study to define the safety of the injection protocol was the optimal volume of injection as a function of homogenous cell deposition in the targeted area and the degree of integrity of the host tissue at the site of injection. As we have demonstrated, the volume of injectate higher The third criterion taken into consideration was the function and that such behavioral improvement corresponds with long-term survival and maturation of optimal total number of cells that can be delivered in a single injection. As we have demonstrated, there was a grafted neurons (8, 27). These initial rodent studies indicate that segment-and laminae-specific cell grafting of clear and extensive tissue expansion in animals injected with 50,000 or 100,000 cells/injection. This tissue human neuronal precursors can represent a viable therapeutic approach in patients suffering from such neurode-expansion was associated with extensive loss of the axodendritic network formed by neurofilament-immunore-generative disorders. From the perspective of clinical application of such active processes of the host. Much less pronounced tissue injury was seen in animals receiving 2,000-30,000 neuraxial cellular replacement, several basic and preclinical translational issues need to be considered. These in-cells/injection. While no permanent neurological deficit was seen in clude: i) escalation of cell dosing when compared across rodent studies, large-animal preclinical models, and hu-any experimental group (A and B), we have concluded that the safe volume of injectate is ≤6 µl and the optimal mans; ii) volume of injections; and, iii) number and segmental/laminar distribution of injections. total number of cells delivered is around 30,000/injection in five bilateral injections (total of 10 injections)
As demonstrated in the present study, the anatomical comparison of the spinal cord between the mouse and format. This assumption was further tested in a separate group of animals that received five bilateral injections the pig, for example, show a more than threefold increase in the lumbar cross-sectional gray matter area (total of 10 injections) of 30,000 cells/injection delivered in 6 µl of media (group C) and showed no detect-measured in the lumbar L2-L4 segments. This simple comparison would lead us to the assumption that a sig-able neurological dysfunction and a comparable distribution of injected cells at 4 weeks after grafting.
nificantly higher number of injected cells (assuming similar morphological phenotype of grafted cells) will Strategies for Multisegmental and Multilaminar Cell be required in larger animal species and in humans in Delivery in Different Animal Species and in Humans order to achieve the same cellular repopulation effect.
To the contrary, despite clear differences in the overall As discussed before, several spinal neurodegenerative disorders such as ALS, multiple sclerosis, spinal ische-gray matter dimensions, the relationship between the size/volume of the gray matter and the total number of mia-induced paraplegia, or hypobaric-induced spinal embolism (4,51) are characterized by a multisegmental neurons is not linear. Previous systematic stereological and tissue volumetric studies have demonstrated that the neuronal/glial degeneration. Recent experimental data using mice and rat transgenic models of ALS or rat spi-total spinal cord gray matter volume in an adult mouse is 25 mm 3 while in the adult rat it is 120 mm 3 . However, nal ischemic paraplegia demonstrate that spinal grafting of rat or human neuronal precursors or human neurons the total number of counted neurons is increased by only 30% in the rat if compared to mouse (6.4 million in the (hNT) derived from the NTera2 teratocarcinoma cell line leads to a clinically relevant improvement in motor rat vs. 4 million in mouse) (5,6). In our current study, we have seen similar differences if comparing the mouse in pig. Similarly, previous studies have demonstrated that the glial index (i.e., number of glial cells/number of versus pig lumbar spinal cord sections. Thus, while the number of neurons was not significantly higher in 10-neurons) is significantly higher in rat than in mouse (1.6 vs. 0.7), indicating that glial cells contribute primarily µm-thick sections, the total gray matter surface area was more than threefold bigger. The total gray matter area to the overall increase in the gray matter volume. These data are in agreement with demonstrated increased con-occupied by neurons was 21% in mice but was only 4% tribution of glial elements in the composition of the gray the naïve noninjured minipig lumbar spinal cord is in the vicinity of 6 µm. As discussed, this volume was not matter in higher mammals.
These anatomical and histological characteristics ap-associated with erratic cell spread around the needle tract and provided a well predictable cell deposition into pear to point to several principal issues that will define our strategies for spinal cell delivery when translated the targeted area; iii) the total number of injections (while cumulatively delivering the similar number of from rodent studies to higher animal species and to humans: i) the total number of cells delivered into a spe-cells) should be increased to permit a more homogenous cell deposition in a larger gray matter area. cific segmental and laminar region should be similar across several species; ii) the volume of injectate can be As discussed in the present study, by using spinal morphological criteria, a safe cell dose was identified to increased in higher species (reflective of the neuropil volume). In the present study, we have shown that the be in the vicinity of 30,000 cells per single injection when delivered in 2-6 µl of vehicle. It needs to be em-maximum safe volume of the individual injections in phasized, however, that this definition strictly reflects Techniques for Spinal Cell Delivery the properties of this particular cell line when grafted into noninjured pig spinal cord and will likely be differ-In our current experiment, a vertically advanced needle was used for spinal parenchymal cell delivery. This ent for other cell lines potentially used for spinal grafting in preclinical animal injury models and in humans.
technique has been used in numerous experimental animal studies including mice, rat, minipig, or nonhuman The variability in the cell dosing between individual cell lines will likely reflect differences in: i) the degree of primate (3,10, 23, 35, 42) and is primarily reflective of the surgical anatomical characteristics of the spinal column proliferation and/or apoptosis after grafting; ii) injury model employed (i.e., cavity-forming injury vs. discrete (i.e., dorsal laminectomy is typically performed to achieve relatively easy access to the dorsal surface of loss of specific cell populations); iii) migration of grafted cells; and, iv) the change in the cell body size the spinal cord). One key limitation of this technique, however, is a relatively small number of injections that during maturation of grafted cells. Accordingly, in several previous studies that demon-can be delivered in a timely fashion. As used in the present study, for example, a total of 10 bilateral injections strated a therapeutic effect after spinal cell grafting of human or rat neural precursors, a variable number of were performed. The average time required to perform one injection is about 4-5 min (including the time of cells delivered in different injection volumes were reported. In a mouse spinal trauma model, for example, cell injection and needle repositioning). Depending on the overall volume of the specific targeted area, it is on average 19,000 cells (human CNS-derived neural precursors) delivered in 250 nl of vehicle were used for estimated that the total number of injections required to achieve a desirable cell repopulation (if multiple seg-spinal grafting. A total of four bilateral injections were used (10). Similarly, using the same human spinal stem ments are targeted) in humans can be in the hundreds. In a recent clinical study, for example, 481 spinal paren-cell line as used in our current minipig study, 50,000 cells in 1 µl of media (total of four bilateral injections) chymal injections were performed on average in patients with spinal traumatic injury (11). Clearly, the time re-were used for spinal grafting in a rat SOD-positive model (49) . In a rat spinal trauma model, 800,000 cells quired to perform such a number of injections, even if performed in an accelerated fashion, is a major limita-(acutely dissociated fetal CNS tissue) delivered in 10 µl into contused T8 spinal segment was reported (36) . In a tion.
Recently, an alternative approach to deliver cells into cat spinal trauma model, a total of 100,000 cells (NRP; mouse lineage-restricted neural precursors) delivered in an injured spinal cord was described by using a direct intrathecal injection of rat neural precursors (21) . Fi-25 µl of media was used to infiltrate contused spinal cord (2) .
nally, intravenous injections of bone marrow cells has been shown to lead to an accumulation of injected cells and lamina. However, as discussed, there is a clear need for the development of new techniques (such as multi-at the spinal cord injury site as defined by MRI and immunohistochemistry (15, 43) . It is unclear whether in-needle devices), which would permit more effective spinal parenchymal cell delivery. tra-arterial delivery of neural precursors will lead to a similarly effective migration of injected cells into spinal Survival and Neuronal Differentiation of HSSC parenchyma if associated with a specific spinal pathol-After Grafting ogy (i.e., spinal trauma with blood-brain barrier opening, or progressive neuronal degeneration as seen in
In the present study, proliferating, nestin-positive HSSC were used for spinal grafting. At 4-7 weeks after ALS or spinal ischemia). However, it is likely that intrathecal or intra-arterial cell delivery, while superior by transplantation the majority of grafted cells developed a neuronal phenotype as evidenced by the expression of the nature of its relative noninvasiveness, will lead to only a limited parenchymal migration and desired multi-the human-specific MOC antibody or coexpression of hNUMA and DCX immunoreactivity. Previous studies segmental cell repopulation. From this perspective, direct parenchymal cell delivery (while more invasive) has have shown that DCX is expressed in early postmitotic spinal cord neurons throughout embryonic and fetal de-a clear advantage as it provides a targeted and wellcontrolled cell delivery into a specific spinal segment velopment, but is absent in the adult nave or traumatic-injured mouse or rat spinal cord (9,12). Similarly, in the ated in lower animals species (32) , based on the data from the rodent studies and current minipig study, we present study, analysis of E86 porcine spinal cord (the total gestational period in pigs is 120 days) showed, in estimate that in the adult porcine spinal cord, 4-6 months will be required to achieve more advanced stage addition to the presence of NeuN-immunoreactive neurons, a clear population of DCX neurons. DCX immuno-of neuronal maturation. reactivity was absent in the adult porcine spinal cord.
Continuing Proliferation of HSSC at 6-7 Weeks These data demonstrate that at 6-7 weeks after grafting After Grafting HSSC-derived neurons are in a relatively early stage of development, with an already developed neuronal phe-In the present study, animals survived 45-55 days after grafting and received BrdU injections during the notype.
In a previous study using HSSC grafted into ische-last 3 days of survival. At this time point, confocal analysis showed some (less than 1-2%) BrdU/hNUMA-mia-injured spinal cord in the rat, we have demonstrated that only a subpopulation of HSSC-derived neurons re-immunoreactive cells. The majority of these cells were found at the periphery of the grafts or appeared to mi-tain DCX immunoreactivity at 3 months after grafting, while the expression of NSE is much more pronounced grate from the injection site. Stereological quantification of grafted cells showed an average of 2-2.5 doublings (8). Previous studies have demonstrated that the NSE is expressed during the advanced stage of neuronal matura-of hNUMA-positive cells. Based on these data, we speculate that the majority of grafted cells will continue to tion and coincides with synapse formation (24) . In accordance with that data in the same rat study, we demon-proliferate shortly after grafting. After this period, however, only small populations of cells will remain mitoti-strated intense human-specific SYN immunoreactivity derived from grafted neurons. In contrast, only very cally active. In a more recently completed study, we have found a similar level of proliferation of HSSC at 9 modest NSE expression was seen in HSSC-derived neurons in the present minipig study. months after grafting into lumbar spinal cord in naive immunodeficient rats. In addition, a robust migration of Jointly, these data indicate that in the porcine spinal cord, a much longer period will be required for full mat-grafted cells in the white and the gray matter was seen (13). In agreement with these data, a similar prolifera-uration of HSSC-derived neurons. While the rate of maturation of grafted human neurons can be influenced by tion and differentiation profile of these cells is reported when grafted spinally in a transgenic ALS rat model the specific signaling system of the host and is acceler- 
